Q9NS23 (RASF1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 110.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Ras association domain-containing protein 1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 344 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Potential tumor suppressor. Required for death receptor-dependent apoptosis. Mediates activation of STK3/MST2 and STK4/MST1 during Fas-induced apoptosis by preventing their dephosphorylation. When associated with MOAP1, promotes BAX conformational change and translocation to mitochondrial membranes in response to TNF and TNFSF10 stimulation. Isoform A interacts with CDC20, an activator of the anaphase-promoting complex, APC, resulting in the inhibition of APC activity and mitotic progression. Inhibits proliferation by negatively regulating cell cycle progression at the level of G1/S-phase transition by regulating accumulation of cyclin D1 protein. Isoform C has been shown not to perform these roles, no function has been identified for this isoform. Isoform A disrupts interactions among MDM2, DAXX and USP7, thus contributing to the efficient activation of TP53 by promoting MDM2 self-ubiquitination in cell-cycle checkpoint control in response to DNA damage. Ref.1 Ref.2 Ref.7 Ref.12 Ref.13 Ref.15 Ref.16 Ref.17 Ref.19 |
| Subunit structure | Interacts with MAP1S and XPA. Binds to the N-terminal of CDC20 during prometaphase. Binds to STK3/MST2 and STK4/MST1. Isoform A interacts with MOAP1 and E4F1. Recruited to the TNFRSF1A and TNFRSF10A complexes in response to their respective cognate ligand, after internalization. Can self-associate. Isoform A interacts with RSSF5 and probably associates with HRAS1 via a RSSF1 isoform A-RSSF5 heterodimer. Part of a complex with MDM2, DAXX, RASSF1 and USP7. Isoform A interacts (via C-terminus) with DAXX (via N-terminus); the interaction is independent of MDM2 and TP53. Isoform C or isoform H interacts (via N-terminus) with DAXX. Isoform A interacts (via N-terminus) with MDM2 (via C-terminus); the interaction is independent of TP53. Ref.1 Ref.8 Ref.10 Ref.11 Ref.12 Ref.13 Ref.14 Ref.15 Ref.16 Ref.17 Ref.19 |
| Subcellular location | Isoform A: Cytoplasm › cytoskeleton. Cytoplasm › cytoskeleton › centrosome. Cytoplasm › cytoskeleton › spindle. Cytoplasm › cytoskeleton › spindle pole. Nucleus. Note: Localizes to cytoplasmic microtubules during interphase, to bipolar centrosomes associated with microtubules during prophase, to spindle fibers and spindle poles at metaphase and anaphase, to the midzone during early telophase, and to the midbody in late telophase in cells. Colocalizes with MDM2 in the nucleus. Ref.12 Ref.17 Isoform C: Nucleus. Note: Predominantly nuclear. Ref.12 Ref.17 |
| Tissue specificity | Isoform A and isoform C are ubiquitously expressed in all tissues tested, however isoform A is absent in many corresponding cancer cell lines. Isoform B is mainly expressed in hematopoietic cells. Ref.1 Ref.2 |
| Sequence similarities | Contains 1 phorbol-ester/DAG-type zinc finger. Contains 1 Ras-associating domain. Contains 1 SARAH domain. |
| Sequence caution | The sequence AAB67312.1 differs from that shown. Reason: Erroneous gene model prediction. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| CDC20 | Q12834 | 2 | EBI-438698,EBI-367462 | |
| E4F1 | Q66K89 | 7 | EBI-438698,EBI-1227043 | |
| EWSR1 | Q01844 | 3 | EBI-438698,EBI-739737 | |
| GABARAP | O95166 | 2 | EBI-367363,EBI-712001 | |
| GABARAPL2 | P60520 | 2 | EBI-367363,EBI-720116 | |
| HRAS | P01112 | 2 | EBI-438698,EBI-350145 | |
| MAP1LC3B | Q9GZQ8 | 2 | EBI-367363,EBI-373144 | |
| MAP1LC3C | Q9BXW4 | 2 | EBI-367363,EBI-2603996 | |
| STK3 | Q13188 | 3 | EBI-438698,EBI-992580 | |
| STK4 | Q13043 | 4 | EBI-438698,EBI-367376 |
Alternative products
| This entry describes 8 isoforms produced by alternative promoter usage and alternative splicing. [Align] [Select] | ||||||
| Isoform D Ref.2 (identifier: Q9NS23-1) Also known as: RASSF1D; Cardiac-specific; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Note: Produced by alternative promoter usage. | ||||||
| Isoform A Ref.1 Ref.2 (identifier: Q9NS23-2) Also known as: RASSF1A; The sequence of this isoform differs from the canonical sequence as follows: 84-88: RLSAD → H | ||||||
| Note: Produced by alternative splicing of isoform D. | ||||||
| Isoform B Ref.1 (identifier: Q9NS23-3) Also known as: RASSF1B; The sequence of this isoform differs from the canonical sequence as follows: 1-155: Missing. | ||||||
| Note: Produced by alternative splicing of isoform D. | ||||||
| Isoform C Ref.1 Ref.2 (identifier: Q9NS23-4) Also known as: RASSF1C; The sequence of this isoform differs from the canonical sequence as follows: 1-74: Missing. 75-123: VVRKGLQCAR...EPAVERDTNV → MGEAEAPSFE...SLARRPRRDQ | ||||||
| Note: Produced by alternative promoter usage. | ||||||
| Isoform E Ref.2 (identifier: Q9NS23-5) Also known as: RASSF1E; Pancreas-specific; The sequence of this isoform differs from the canonical sequence as follows: 84-88: RLSAD → H 123-123: V → VPILQ | ||||||
| Note: Produced by alternative splicing of isoform D. | ||||||
| Isoform F Ref.2 (identifier: Q9NS23-6) Also known as: RASSF1F; The sequence of this isoform differs from the canonical sequence as follows: 85-91: LSADCKF → RACGVGD 93-344: Missing. | ||||||
| Note: Produced by alternative splicing of isoform D. | ||||||
| Isoform G Ref.2 (identifier: Q9NS23-7) Also known as: RASSF1G; The sequence of this isoform differs from the canonical sequence as follows: 84-149: RLSADCKFTC...EQKIKEYNAQ → QQGRFLHRLH...PACAVTHKGT 150-344: Missing. | ||||||
| Note: Produced by alternative splicing of isoform D. | ||||||
| Isoform H (identifier: Q9NS23-9) The sequence of this isoform differs from the canonical sequence as follows: 1-74: Missing. 75-123: VVRKGLQCAR...EPAVERDTNV → MGEAEAPSFE...SLARRPRRDQ 150-344: Missing. | ||||||
| Note: Produced by alternative splicing of isoform C. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed Ref.18 | ||||||
| Chain | 2 – 344 | 343 | Ras association domain-containing protein 1 | PRO_0000068891 | |||||
Regions | |||||||||
| Domain | 198 – 292 | 95 | Ras-associating | ||||||
| Domain | 294 – 341 | 48 | SARAH | ||||||
| Zinc finger | 51 – 105 | 55 | Phorbol-ester/DAG-type | ||||||
| Region | 2 – 119 | 118 | Mediates interaction with E4F1 | ||||||
| Region | 315 – 318 | 4 | MOAP1-binding | ||||||
Amino acid modifications | |||||||||
| Modified residue | 2 | 1 | N-acetylserine Ref.18 | ||||||
| Modified residue | 2 | 1 | Phosphoserine Ref.18 | ||||||
Natural variations | |||||||||
| Alternative sequence | 1 – 155 | 155 | Missing in isoform B. Ref.1 | VSP_050770 | |||||
| Alternative sequence | 1 – 74 | 74 | Missing in isoform C and isoform H. Ref.1 Ref.2 | VSP_050773 | |||||
| Alternative sequence | 75 – 123 | 49 | VVRKG…RDTNV → MGEAEAPSFEMTWSSTTSSG YCSQEDSDSELEQYFTARTS LARRPRRDQ in isoform C and isoform H. Ref.1 Ref.2 | VSP_050774 | |||||
| Alternative sequence | 84 – 149 | 66 | RLSAD…EYNAQ → QQGRFLHRLHQGSAEAGAPC LCALQQEATLLAGCPAGPRT GHKCQAPHFLLPAQGCCQAP ACAVTHKGT in isoform G. Ref.2 | VSP_050775 | |||||
| Alternative sequence | 84 – 88 | 5 | RLSAD → H in isoform A and isoform E. Ref.1 Ref.2 | VSP_050771 | |||||
| Alternative sequence | 85 – 91 | 7 | LSADCKF → RACGVGD in isoform F. Ref.2 | VSP_050776 | |||||
| Alternative sequence | 93 – 344 | 252 | Missing in isoform F. Ref.2 | VSP_050777 | |||||
| Alternative sequence | 123 | 1 | V → VPILQ in isoform E. Ref.2 | VSP_050772 | |||||
| Alternative sequence | 150 – 344 | 195 | Missing in isoform G and isoform H. Ref.2 | VSP_050778 | |||||
| Natural variant | 21 | 1 | K → Q. Ref.1 Ref.2 Corresponds to variant rs4688725 [ dbSNP | Ensembl ]. | VAR_019542 | |||||
| Natural variant | 53 | 1 | R → C. Ref.2 | VAR_019543 | |||||
| Natural variant | 133 | 1 | D → E. Ref.2 | VAR_019544 | |||||
| Natural variant | 135 | 1 | S → F Prevents G1 cell cycle arrest; reduced protein phosphorylation. Ref.7 | VAR_019545 | |||||
| Natural variant | 137 | 1 | A → S Prevents G1 cell cycle arrest; reduced protein phosphorylation. Ref.2 Ref.7 Corresponds to variant rs2073498 [ dbSNP | Ensembl ]. | VAR_019546 | |||||
| Natural variant | 319 | 1 | H → R. Corresponds to variant rs12488879 [ dbSNP | Ensembl ]. | VAR_059794 | |||||
| Natural variant | 329 | 1 | Y → C. Ref.2 | VAR_019547 | |||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3." Dammann R., Li C., Yoon J.-H., Chin P.L., Bates S., Pfeifer G.P. Nat. Genet. 25:315-319(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A; B AND C), FUNCTION, TISSUE SPECIFICITY, VARIANT GLN-21, INTERACTION WITH XPA. |
| [2] | "Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression." Burbee D.G., Forgacs E., Zochbauer-Muller S., Shivakumar L., Fong K., Gao B., Randle D., Kondo M., Virmani A., Bader S., Sekido Y., Latif F., Milchgrub S., Toyooka S., Gazdar A.F., Lerman M.I., Zabarovsky E., White M., Minna J.D. J. Natl. Cancer Inst. 93:691-699(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A; C; D; E; F AND G), FUNCTION, TISSUE SPECIFICITY, VARIANTS GLN-21; CYS-53; GLU-133; SER-137 AND CYS-329. Tissue: Heart, Lung and Pancreas. |
| [3] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM C). |
| [4] | "The DNA sequence, annotation and analysis of human chromosome 3." Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J. Gibbs R.A.Nature 440:1194-1198(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS A AND B). Tissue: Blood and Brain. |
| [7] | "The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation." Shivakumar L., Minna J., Sakamaki T., Pestell R., White M.A. Mol. Cell. Biol. 22:4309-4318(2002) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, VARIANT PHE-135, CHARACTERIZATION OF VARIANTS PHE-135 AND SER-137. |
| [8] | "The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1." Ortiz-Vega S., Khokhlatchev A., Nedwidek M., Zhang X.F., Dammann R., Pfeifer G.P., Avruch J. Oncogene 21:1381-1390(2002) [PubMed] [Europe PMC] [Abstract] Cited for: SELF-ASSOCIATION, INTERACTION WITH RSSF5 AND HRAS1. |
| [9] | Erratum Ortiz-Vega S., Khokhlatchev A., Nedwidek M., Zhang X.F., Dammann R., Pfeifer G.P., Avruch J. Oncogene 21:1943-1943(2002) |
| [10] | "Identification of the E1A-regulated transcription factor p120 E4F as an interacting partner of the RASSF1A candidate tumor suppressor gene." Fenton S.L., Dallol A., Agathanggelou A., Hesson L., Ahmed-Choudhury J., Baksh S., Sardet C., Dammann R., Minna J.D., Downward J., Maher E.R., Latif F. Cancer Res. 64:102-107(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH E4F1. |
| [11] | "RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics." Dallol A., Agathanggelou A., Fenton S.L., Ahmed-Choudhury J., Hesson L., Vos M.D., Clark G.J., Downward J., Maher E.R., Latif F. Cancer Res. 64:4112-4116(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH MAP1S. |
| [12] | "The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex." Song M.S., Song S.J., Ayad N.G., Chang J.S., Lee J.H., Hong H.K., Lee H., Choi N., Kim J., Kim H., Kim J.W., Choi E.-J., Kirschner M.W., Lim D.-S. Nat. Cell Biol. 6:129-137(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH CDC20. |
| [13] | "Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras." Praskova M., Khoklatchev A., Ortiz-Vega S., Avruch J. Biochem. J. 381:453-462(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH STK3/MST2 AND STK4/MST1. |
| [14] | "Specificity of the methylation-suppressed A isoform of candidate tumor suppressor RASSF1 for microtubule hyperstabilization is determined by cell death inducer C19ORF5." Liu L., Vo A., McKeehan W.L. Cancer Res. 65:1830-1838(2005) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH MAP1S. |
| [15] | "The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death." Baksh S., Tommasi S., Fenton S., Yu V.C., Martins L.M., Pfeifer G.P., Latif F., Downward J., Neel B.G. Mol. Cell 18:637-650(2005) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH MOAP1, FUNCTION. |
| [16] | "Role of the tumor suppressor RASSF1A in Mst1-mediated apoptosis." Oh H.J., Lee K.-K., Song S.J., Jin M.S., Song M.S., Lee J.H., Im C.R., Lee J.-O., Yonehara S., Lim D.-S. Cancer Res. 66:2562-2569(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH STK3/MST2 AND STK4/MST1. |
| [17] | "The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex." Song M.S., Song S.J., Kim S.Y., Oh H.J., Lim D.S. EMBO J. 27:1863-1874(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, IDENTIFICATION IN A COMPLEX WITH MDM2; DAXX AND USP7, INTERACTION WITH DAXX AND MDM2, SUBCELLULAR LOCATION. |
| [18] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2, MASS SPECTROMETRY, CLEAVAGE OF INITIATOR METHIONINE. |
| [19] | "The tumor suppressor RASSF1A prevents dephosphorylation of the mammalian STE20-like kinases MST1 and MST2." Guo C., Zhang X., Pfeifer G.P. J. Biol. Chem. 286:6253-6261(2011) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH STK3/MST2 AND STK4/MST1. |
| [20] | "Structural characterization of the DAXX N-terminal helical bundle domain and its complex with Rassf1C." Escobar-Cabrera E., Lau D.K., Giovinazzi S., Ishov A.M., McIntosh L.P. Structure 18:1642-1653(2010) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR (ISOFORM C/H) IN COMPLEX WITH DAXX. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF061836 mRNA. Translation: AAC16001.1. AF132675 mRNA. Translation: AAD44174.1. AF132676 mRNA. Translation: AAD44175.1. AF132677 mRNA. Translation: AAD44176.1. AF040703 mRNA. Translation: AAC70910.2. AF102770 mRNA. Translation: AAF35127.2. AF102771 mRNA. Translation: AAF35128.2. AF102772 mRNA. Translation: AAF35129.2. BT020047 mRNA. Translation: AAV38850.1. BT020048 mRNA. Translation: AAV38851.1. AF286217 mRNA. Translation: AAG10038.1. AF291719 mRNA. Translation: AAG10064.1. AC002455 Genomic DNA. No translation available. AC002481 Genomic DNA. Translation: AAB67312.1. Sequence problems. CH471055 Genomic DNA. Translation: EAW65098.1. CH471055 Genomic DNA. Translation: EAW65101.1. CH471055 Genomic DNA. Translation: EAW65102.1. BC110412 mRNA. Translation: AAI10413.1. BC143879 mRNA. Translation: AAI43880.1. | ||||||||||||
| IPI | IPI00172514. IPI00172661. IPI00221057. IPI00395780. IPI00426162. IPI00426164. IPI00426165. IPI00455193. | ||||||||||||
| RefSeq | NP_001193886.1. NM_001206957.1. NP_009113.3. NM_007182.4. NP_733830.1. NM_170712.2. NP_733831.1. NM_170713.2. NP_733832.1. NM_170714.1. | ||||||||||||
| UniGene | Hs.476270. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q9NS23. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-31270N. | ||||||||||||
| IntAct | Q9NS23. 20 interactions. | ||||||||||||
| MINT | MINT-146049. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q9NS23. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 50401686. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q9NS23. | ||||||||||||
| PRIDE | Q9NS23. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 11186. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000327761; ENSP00000333327; ENSG00000068028. ENST00000357043; ENSP00000349547; ENSG00000068028. ENST00000359365; ENSP00000352323; ENSG00000068028. ENST00000395117; ENSP00000378549; ENSG00000068028. ENST00000395126; ENSP00000378558; ENSG00000068028. ENST00000482447; ENSP00000433000; ENSG00000068028. ENST00000571713; ENSP00000460113; ENSG00000263005. ENST00000573573; ENSP00000458429; ENSG00000263005. ENST00000574064; ENSP00000460844; ENSG00000263005. ENST00000575029; ENSP00000458147; ENSG00000263005. ENST00000575676; ENSP00000461709; ENSG00000263005. ENST00000576813; ENSP00000460729; ENSG00000263005. | ||||||||||||
| GeneID | 11186. | ||||||||||||
| KEGG | hsa:11186. | ||||||||||||
| UCSC | uc003daa.1. human. uc003dab.1. human. uc003dae.1. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 11186. | ||||||||||||
| GeneCards | GC03M050369. | ||||||||||||
| HGNC | HGNC:9882. RASSF1. | ||||||||||||
| HPA | HPA040735. | ||||||||||||
| MIM | 605082. gene. | ||||||||||||
| neXtProt | NX_Q9NS23. | ||||||||||||
| PharmGKB | PA34245. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG308852. | ||||||||||||
| HOVERGEN | HBG054362. | ||||||||||||
| InParanoid | Q9NS23. | ||||||||||||
| KO | K09850. | ||||||||||||
| OMA | PRRDQDE. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| SignaLink | Q9NS23. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q9NS23. | ||||||||||||
| Bgee | Q9NS23. | ||||||||||||
| Genevestigator | Q9NS23. | ||||||||||||
| GermOnline | ENSG00000068028. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR002219. Prot_Kinase_C-like_PE/DAG-bd. IPR000159. Ras-assoc. IPR011524. SARAH_dom. [Graphical view] | ||||||||||||
| Pfam | PF00130. C1_1. 1 hit. PF00788. RA. 1 hit. [Graphical view] | ||||||||||||
| SMART | SM00109. C1. 1 hit. SM00314. RA. 1 hit. [Graphical view] | ||||||||||||
| PROSITE | PS50200. RA. 1 hit. PS50951. SARAH. 1 hit. PS00479. ZF_DAG_PE_1. False negative. PS50081. ZF_DAG_PE_2. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| EvolutionaryTrace | Q9NS23. | ||||||||||||
| GenomeRNAi | 11186. | ||||||||||||
| NextBio | 42571. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | RASF1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9NS23 Secondary accession number(s): B7ZLL1 Q9UND5 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 3 Human chromosome 3: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
